Scios To Launch Heart Failure Registry Simultaneous With Natrecor Marketing
Executive Summary
Scios will initiate a congestive heart failure patient registry in conjunction with the launch of Natrecor (nesiritide) for treatment of acute decompensated CHF, CEO Richard Brewer said July 10.